Hematological Toxicity During Consolidation
| . | Consolidation No. 1 N = 99 . | Consolidation No. 2 N = 95 . | Consolidation No. 3 N = 92 . |
|---|---|---|---|
| Days to PMN >1 × 109/L | |||
| No neutropenia | 71 (72) | 6 (6) | 77 (83) |
| ≤15 d | 10 (10) | 5 (5) | 7 (8) |
| >15 d | 18 (18) | 84 (89) | 8 (9) |
| Days to platelets >50 × 109/L | |||
| No thrombocytopenia | 81 (82) | 18 (19) | 82 (89) |
| ≤15 d | 10 (10) | 9 (10) | 5 (6) |
| >15 d | 8 (8) | 67 (71) | 5 (5) |
| Episodes of fever | 14 (14) | 63 (66) | 7 (8) |
| . | Consolidation No. 1 N = 99 . | Consolidation No. 2 N = 95 . | Consolidation No. 3 N = 92 . |
|---|---|---|---|
| Days to PMN >1 × 109/L | |||
| No neutropenia | 71 (72) | 6 (6) | 77 (83) |
| ≤15 d | 10 (10) | 5 (5) | 7 (8) |
| >15 d | 18 (18) | 84 (89) | 8 (9) |
| Days to platelets >50 × 109/L | |||
| No thrombocytopenia | 81 (82) | 18 (19) | 82 (89) |
| ≤15 d | 10 (10) | 9 (10) | 5 (6) |
| >15 d | 8 (8) | 67 (71) | 5 (5) |
| Episodes of fever | 14 (14) | 63 (66) | 7 (8) |